In a first study they analyzed 23 individuals with biallelic PRF1 mutations whose onset of FHL was delayed or abolished and found that 11/23 presented as the primary clinical illness with B- or T-cell lymphoma or acute or chronic leukemia (128). This evidence concerns the gene PRF1 and hemophagocytic syndrome.